Norman Payson Sells 6,618 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Norman Payson Sells 6,618 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Director Norman Payson sold 6,618 shares of the firm's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $32.27, for a total value of $213,562.86. Following the transaction, the director now directly owns 411,412 shares of the company's stock, valued at approximately $13,276,265.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
納斯達克：PGNY-GET評級)董事諾曼·佩森在8月3日週三的一筆交易中出售了6618股該公司股票。這些股票的平均價格為32.27美元，總價值為213,562.86美元。交易完成後，董事現在直接持有該公司411,412股股票，價值約13,276,265.24美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，這份文件可以在美國證券交易委員會的網站上找到。
Norman Payson also recently made the following trade(s):
諾曼·佩森最近還進行了以下交易：
- On Wednesday, July 20th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $33.40, for a total value of $221,041.20.
- On Wednesday, July 6th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $29.38, for a total value of $194,436.84.
- On Wednesday, June 22nd, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $27.35, for a total value of $181,002.30.
- On Wednesday, May 25th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $32.09, for a total value of $212,371.62.
- On Wednesday, May 11th, Norman Payson sold 6,618 shares of Progyny stock. The stock was sold at an average price of $33.45, for a total value of $221,372.10.
- 7月20日，星期三，諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為33.40美元，總價值為221,041.20美元。
- 7月6日，星期三，諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為29.38美元，總價值為194,436.84美元。
- 6月22日，星期三，諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為27.35美元，總價值為181,002.30美元。
- 5月25日，星期三，諾曼·佩森出售了6,618股Progyny股票。這些股票的平均價格為32.09美元，總價值為212,371.62美元。
- 5月11日，星期三，諾曼·佩森出售了6,618股Progyny股票。這隻股票的平均售價為33.45美元，總價值為221,372.10美元。
Progyny Price Performance
孕期性價比
PGNY opened at $41.15 on Friday. The stock has a 50-day moving average price of $30.23 and a 200-day moving average price of $37.32. The firm has a market cap of $3.78 billion, a PE ratio of 89.46, a P/E/G ratio of 15.71 and a beta of 1.85. Progyny, Inc. has a 1 year low of $25.67 and a 1 year high of $68.32.
上週五，紐約商品交易所開盤報41.15美元。該股的50日移動均線價格為30.23美元，200日移動均線價格為37.32美元。該公司市值為37.8億美元，市盈率為89.46倍，市盈率為15.71倍，貝塔係數為1.85。Progyny，Inc.的一年低點為25.67美元，一年高位為68.32美元。
Hedge Funds Weigh In On Progyny
對衝基金對Progyny的看法
Several large investors have recently modified their holdings of PGNY. National Bank of Canada FI purchased a new position in shares of Progyny in the 2nd quarter worth about $29,000. First Horizon Advisors Inc. raised its position in Progyny by 1,469.4% in the 4th quarter. First Horizon Advisors Inc. now owns 769 shares of the company's stock worth $38,000 after buying an additional 720 shares during the last quarter. Fifth Third Bancorp raised its position in Progyny by 1,532.4% in the 4th quarter. Fifth Third Bancorp now owns 1,208 shares of the company's stock worth $61,000 after buying an additional 1,134 shares during the last quarter. Steward Partners Investment Advisory LLC raised its position in Progyny by 44.8% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,209 shares of the company's stock worth $61,000 after buying an additional 374 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new position in Progyny in the 1st quarter worth about $62,000. Hedge funds and other institutional investors own 82.51% of the company's stock.
幾家大型投資者最近調整了對PGNY的持股。加拿大國民銀行FI在第二季度購買了Progyny的新頭寸，價值約29,000美元。First Horizon Advisors Inc.在第四季度將其在Progyny的頭寸提高了1,469.4%。First Horizon Advisors Inc.現在持有該公司769股股票，價值3.8萬美元，該公司在上個季度又購買了720股。Five Third Bancorp在第四季度將其在Progyny的頭寸提高了1,532.4%。Five Third Bancorp現在擁有1,208股該公司股票，價值61,000美元，在上個季度又購買了1,134股。Steward Partners Investment Consulting LLC在第四季度將其在Progyny的頭寸提高了44.8%。Steward Partners Investment Consulting LLC現在擁有1,209股該公司股票，價值61,000美元，上個季度又購買了374股。最後，Lazard Asset Management LLC在第一季度購買了Progyny的一個新頭寸，價值約62,000美元。對衝基金和其他機構投資者持有該公司82.51%的股票。
About Progyny
關於Progyny
(Get Rating)
(獲取評級)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- Why Apple Could Be At All-Time Highs By Year End
- 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
- MarketBeat：回顧中的一週8/1-8/5
- 如何利用高貝塔係數股票最大化你的投資利潤
- 克羅諾斯集團(Cronos Group Inc.)營收上升，是時候收購了嗎？
- Beyond Meat不是沒有希望，而且它很便宜
- 蘋果為何可能在年底創下歷史新高
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。